Anderson PL - Search Results

1

Population pharmacokinetic modeling of plasma and intracellular ribavirin concentrations in patients with chronic hepatitis C virus infection.

Wu LS, Rower JE, Burton JR Jr, Anderson PL, Hammond KP, Baouchi-Mokrane F, Everson GT, Urban TJ, D'Argenio DZ, Kiser JJ. Wu LS, et al. Among authors: anderson pl. Antimicrob Agents Chemother. 2015 Apr;59(4):2179-88. doi: 10.1128/AAC.04618-14. Epub 2015 Feb 2. Antimicrob Agents Chemother. 2015. PMID: 25645847 Free PMC article. Clinical Trial.

2

Therapeutic drug monitoring: pharmacologic considerations for antiretroviral drugs.

Kiser JJ, Anderson PL, Gerber JG. Kiser JJ, et al. Among authors: anderson pl. Curr HIV/AIDS Rep. 2005 Jun;2(2):61-7. doi: 10.1007/s11904-005-0020-8. Curr HIV/AIDS Rep. 2005. PMID: 16091250 Review.

3

6th International Workshop on Clinical Pharmacology of HIV Therapy.

Kiser JJ, Anderson PL, Kakuda TN. Kiser JJ, et al. Among authors: anderson pl. Expert Opin Pharmacother. 2006 Feb;7(2):229-41. doi: 10.1517/14656566.7.2.229. Expert Opin Pharmacother. 2006. PMID: 16433587

4

Effects of esomeprazole on the pharmacokinetics of atazanavir and fosamprenavir in a patient with human immunodeficiency virus infection.

Kiser JJ, Lichtenstein KA, Anderson PL, Fletcher CV. Kiser JJ, et al. Among authors: anderson pl. Pharmacotherapy. 2006 Apr;26(4):511-4. doi: 10.1592/phco.26.4.511. Pharmacotherapy. 2006. PMID: 16553510

5

Liquid chromatography-tandem mass spectrometric determination of tenofovir-diphosphate in human peripheral blood mononuclear cells.

King T, Bushman L, Kiser J, Anderson PL, Ray M, Delahunty T, Fletcher CV. King T, et al. Among authors: anderson pl. J Chromatogr B Analyt Technol Biomed Life Sci. 2006 Nov 7;843(2):147-56. doi: 10.1016/j.jchromb.2006.05.043. Epub 2006 Jul 7. J Chromatogr B Analyt Technol Biomed Life Sci. 2006. PMID: 16828350

6

Atazanavir-containing renal calculi in an HIV-infected patient.

Anderson PL, Lichtenstein KA, Gerig NE, Kiser JJ, Bushman LR. Anderson PL, et al. AIDS. 2007 May 11;21(8):1060-2. doi: 10.1097/QAD.0b013e3280c56ae1. AIDS. 2007. PMID: 17457108 No abstract available.

7

The effect of lopinavir/ritonavir on the renal clearance of tenofovir in HIV-infected patients.

Kiser JJ, Carten ML, Aquilante CL, Anderson PL, Wolfe P, King TM, Delahunty T, Bushman LR, Fletcher CV. Kiser JJ, et al. Among authors: anderson pl. Clin Pharmacol Ther. 2008 Feb;83(2):265-72. doi: 10.1038/sj.clpt.6100269. Epub 2007 Jun 27. Clin Pharmacol Ther. 2008. PMID: 17597712 Clinical Trial.

8

Clinical and genetic determinants of intracellular tenofovir diphosphate concentrations in HIV-infected patients.

Kiser JJ, Aquilante CL, Anderson PL, King TM, Carten ML, Fletcher CV. Kiser JJ, et al. Among authors: anderson pl. J Acquir Immune Defic Syndr. 2008 Mar 1;47(3):298-303. doi: 10.1097/qai.0b013e31815e7478. J Acquir Immune Defic Syndr. 2008. PMID: 18398970 Clinical Trial.

9

Cytokine and sex hormone effects on zidovudine- and lamivudine-triphosphate concentrations in vitro.

Anderson PL, King T, Zheng JH, MaWhinney S. Anderson PL, et al. J Antimicrob Chemother. 2008 Oct;62(4):738-45. doi: 10.1093/jac/dkn247. Epub 2008 Jun 20. J Antimicrob Chemother. 2008. PMID: 18567572 Free PMC article.

10

Atazanavir pharmacokinetics in genetically determined CYP3A5 expressors versus non-expressors.

Anderson PL, Aquilante CL, Gardner EM, Predhomme J, McDaneld P, Bushman LR, Zheng JH, Ray M, MaWhinney S. Anderson PL, et al. J Antimicrob Chemother. 2009 Nov;64(5):1071-9. doi: 10.1093/jac/dkp317. Epub 2009 Aug 26. J Antimicrob Chemother. 2009. PMID: 19710077 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

348 results

Search Page

Filters